Phase 2 Nausea Clinical Trials

15 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 115 of 15 trials

Recruiting
Phase 2

Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery

AnesthesiaSpinal FusionNausea and Vomiting, Postoperative
IWK Health Centre100 enrolled1 locationNCT06357234
Recruiting
Phase 2

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

NeoplasmsVomitingNausea+1 more
Eli Lilly and Company204 enrolled66 locationsNCT07169851
Recruiting
Phase 2

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Trastuzumab Deruxtecan

Nausea and Vomiting Caused by Trastuzumab Deruxtecan
Second Affiliated Hospital, School of Medicine, Zhejiang University25 enrolled1 locationNCT07537673
Recruiting
Phase 2

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide

Nausea and Vomiting Caused by Chemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University25 enrolled1 locationNCT07537699
Recruiting
Phase 2

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Gemcitabine Plus Paclitaxel

Nausea and Vomiting Caused by Chemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University25 enrolled1 locationNCT07537660
Recruiting
Phase 2

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Nausea and Vomiting Chemotherapy-InducedNausea Post Chemotherapy
Helsinn Healthcare SA95 enrolled20 locationsNCT06904235
Recruiting
Phase 2Phase 3

Inhaled Isopropyl Alcohol for Treatment of Nausea

VomitingChildren, OnlyNausea
State University of New York at Buffalo84 enrolled1 locationNCT05418244
Recruiting
Phase 2

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

OncologyHematopoietic System--CancerNausea+1 more
The Hospital for Sick Children200 enrolled10 locationsNCT03118986
Recruiting
Phase 2Phase 3

Antiemetic Fosaprepitant To Remedy Nausea and Vomiting

Nausea and VomitingVomitingNausea
Montefiore Medical Center250 enrolled1 locationNCT06382012
Recruiting
Phase 2

Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk for Nausea and Vomiting Undergoing Gynecological Surgery

Post Operative Nausea and Vomiting (PONV)
Instituto do Cancer do Estado de São Paulo276 enrolled1 locationNCT06887621
Completed
Phase 2

Management of nausea in cancer patients – Nausea study 4 pilot

Advanced CancerNausea
The University of Technology Sydney24 enrolled1 locationACTRN12619000744156
Completed
Phase 2

A study that evaluates the effectiveness of oral combined THC/CBD for people with advanced cancer experiencing a range of symptoms.

Psychological effectsCancerFatigue+3 more
Mater Misericordiae Limited144 enrolled6 locationsACTRN12619000037101
Completed
Phase 2

A study that evaluates the effectiveness of oral medicinal cannabis for people with advanced cancer experiencing a range of symptoms.

Psychological effectsCancerFatigue+3 more
Mater Misericordiae Limited144 enrolled6 locationsACTRN12618001220257
Recruiting
Phase 2Phase 3

Comparison of 0.8% sevoflurane versus Entonox for labour analgesia

Active Labour in healthy parturientsPost analgesic nausea and vomitingShort term memory and amnesic effects of sevoflurane and entonox
University of Malaya46 enrolled1 locationACTRN12614000805673
Completed
Phase 2

Aprepitant for Germ Cell Chemotherapy: A phase II multi-centre trial of a seven day Aprepitant schedule for the prevention of chemotherapy induced nausea and vomiting in patients receiving five day cisplatin-based chemotherapy for germ cell tumours.

Prevention of chemotherapy-induced nausea and vomiting for patients being treated for germ cell tumours.
The University of Sydney50 enrolled1 locationACTRN12608000254392